Patent · US Active

Compositions and methods

US11162944B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2016
Grant dateNov 2, 2021
Priority date
Expiry dateNov 19, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2469/20
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of determining whether an individual is infected with a mycobacterial disease, the method comprising: (a) providing a system which comprises an antigen; (b) contacting the system with a sample obtained from the individual; and (c) detecting the presence or absence of binding of a biomarker in the sample with the antigen; wherein the antigen is an arabinose ester of a mycolic acid or an analogue thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.